RTTNews | Jan 19, 2022 01:02AM EST

01:01 Wednesday, January 19, 2022 (RTTNews) - Regeneron And Sanofi Say Phase 3 Dupixent Trial Confirms Significant Improvements For Patients With Prurigo Nodularis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved